0 items USD 0.00Search
Your search for "globaldata cancer anorexia cachexia syndrome global clinical trials review h2 2018" gave back 819845 results.
The global Cancer Anorexia-Cachexia Syndrome Drug market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
The global Cancer Cachexia market size was valued at US$ 1578.4 million in 2023. With growing demand in downstream market, the Cancer Cachexia is...
Catalog:
LPI
March 2024
Price: USD 3,660.00
Cancer cachexia is a wasting syndrome characterized by weight loss, anorexia, asthenia and anemia. The pathogenicity of this syndrome is...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Cancer cachexia is a wasting syndrome characterized by weight loss, anorexia, asthenia and anemia. The pathogenicity of this syndrome is...
Catalog:
MRRPB5
May 2023
Price: USD 4,900.00
Cachexia is a wasting syndrome characterized by extreme weight loss, anorexia, asthenia and anaemia. This syndrome affects populations who were in...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Cachexia is a wasting syndrome characterized by extreme weight loss, anorexia, asthenia and anaemia. This syndrome affects populations who were in...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Bispecific T-cell engager (BiTE) stands out as a novel subclass of T-cell engaging bsAbs with promising clinical results in the treatment of cancers...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Bispecific T-cell engager (BiTE) stands out as a novel subclass of T-cell engaging bsAbs with promising clinical results in the treatment of cancers...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Bispecific T-cell engager (BiTE) stands out as a novel subclass of T-cell engaging bsAbs with promising clinical results in the treatment of cancers...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Bispecific T-cell engager (BiTE) stands out as a novel subclass of T-cell engaging bsAbs with promising clinical results in the treatment of cancers...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Bladder Cancer Clinical trials are research studies that involve people. The clinical trials on this list are for bladder cancer treatment. ... This...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
A Bispecific Antibodies is designed to bind two different targets or epitopes and can thereby exert two different functions. They are currently used...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Clinical trials are the final step in a long process that begins with research in a lab. Market Analysis and Insights: Global Oncology Clinical Trial...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Bispecific T-cell engager (BiTE) stands out as a novel subclass of T-cell engaging bsAbs with promising clinical results in the treatment of cancers...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Bispecific T-cell engager (BiTE) stands out as a novel subclass of T-cell engaging bsAbs with promising clinical results in the treatment of cancers...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
